DNA Home Kits vs EWBC Genetic Counseling

  • The newly announced 23andMe direct-to consumer genetic testing assesses only three out of the more than 1,000 known BRCA1 and BRCA2 mutations.
  • These specific mutations are most common in people with Eastern European (Ashkenazi) Jewish descent and are exceedingly rare in patients without known Ashkenazi heritage.
  • While the  23andMe saliva test creates an affordable option and increased access to genetic testing, it is only appropriate for a small number of at-risk patients.
  • Most high risk women would benefit from a wider assessment of the BRCA genes and other recognized breast cancer causing genes.
  • A negative result from 23andMe does not rule-out the possibility that an individual actually carries a mutation that increases his or her cancer risk.

Genetic counseling is key to educating patients on risk, cost and the recommended management guidelines. Counseling services are typically covered by insurance and are available at the EWBC Brighton office. Questions, please call  (585) 758-7041

GENETICS COMMUNITY INFORMATION SESSION: If you have questions regarding your risk status and wonder if you are an appropriate candidate for genetic testing, please come to an information session.

2019 Dates at 5:30pm | Main Lobby Brighton Office
Monday, January 21  | Monday, March 11  |  Monday, May 20  | Monday, July 20

Please sign up at 585-758-7041

Watch Channel 10 (Video on home DNA kits- March 2018)
Watch Channel 8 (FDA approves first direct-to-consumer test for breast cancer, but there are concerns – March 2018)